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Abstract. In the first experiment, adult male Swiss- 
Webster mice were systemically injected with a stan- 
dard dose of morphine. Compared to the influence of 
vehicle, the motor activity of morphine-injected mice 
was increased. Neither phenytoin sodium nor carbama- 
zepine alone facilitated motor activity, but pretreat- 
ment with both drugs further facilitated the increased 
motor activity produced by morphine. In a second 
experiment, mice were injected centrally with a long- 
acting analog ofleu-enkephalin. It also increased motor 
activity in comparison with vehicle~ Again, both pheny- 
toin sodium and carbamazepine further facilitated this 
response. Both experiments suggest a facilitatory in- 
teraction between some aspects of these anticonvul- 
sants and opiate-induced motor activity. 
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Morphine, enkephalin, and e!ectrical stimulation of 
endorphin-rich brain areas are known to produce both 
local changes in multiple unit activity and more general 
eiectrocortical effects, including seizures. (Frenk etal. ,  
1978' Rhodes and Liebeskind, 1978; Tortel!a et al., 
1978; Urca et al., 1977). These findings are consistent 
with and extend prior studies establishing a stereospe- 
cific and naloxone-reversible proconvulsant effect of a 
number of opiates (e.g., Mannino and Wolf, 1974, 
1975) and may have additional functional significance. 
Local changes in unit firing rate, especially within the 
periaqueductal grey area (PAG), correlate with anal- 
gesia (Rhodes and Liebeskind, 1978; Urca et al., 1977), 
while EEG seizures in other brain areas (e.g., cortical 
seizures) have been correlated with catalepsy and signs 
of opiate withdrawal such as wet dog shakes and 
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twitches (Frenk et al., 1978). It is therefore possible that 
local PAG unit changes and more general electrocorti- 
cal alterations in fact mediate different aspects of the 
morphine response. Given the above possiblity, we 
tested interactions of opiates and an enkephalin analog 
with drugs which have clinical efficacy in reducing 
seizures as one of their actions. The models we used for 
investigating these effects involved motor activity in 
grouped and individual mice after systemic morphine 
or central D-Ala2Leu Enkephalinamide, respectively. 
This model draws upon the initial studies of Goldstein 
and Sheehan (1969), and related effects have been 
found by us (Carroli and Sharp, 1972; Katz et al., 
1978a, b) and others (e.g., Bhargava, !978; Pert and 
Sivit, 1977). 
In the present two experiments, we tested animals 
with and without phenytoin sodium and carbama- 
zepine, which are known to be clinically effective in 
reducing seizures (Woodbury and Eingl, (1975). 
Experiment I examined interactions with morphine, 
and Experiment II utilized running, with an enkephalin 
analog as the basis of comparison. Our findings suggest 
these compounds may selectively fad!irate opiate- 
induced activity. 
Experiment i 
Experiment 2[ examined the effect of drug pretreatment 
upon morphine-induced running in grouped mice. 
General Materials' and Methods 
Sublects. Experimentally naive, adult male Swiss-Webster mice 
(N 245) (30- 40 g) (Charles River Farms, Portage, M!) maintained 
on ad libitum food (Teklad 4.0 ~/o fat diet S-0836) and tap u ater, with 
automatically programmed 12-h day-night cycles (lights on 8 a.m.). 
Group housing was employed for the first experiment with four to six 
subjects per cage. Individual housing was employed in the second 
experiment to protect surgically implanted cannu!ae. 
Apparatus. In both experiments field sensitive activity monitors 
(Stoelting, Chicago) were used cal brated to within 5 ~/o of each other. 
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Fig. l, Phenytoin facilitation of morphine-induced running in the 
mouse. Each data point represents the mean + SD of the activity 
counts for each experimental group at indicated times : Saline vehicle 
(S); A phenytoin (P) (20 mg/kg); [] morphine (M) (50 mg/kg) ; 9 Mor- 
phine (50 mg/kg) + phenytoin (5 mg/kg); 9 morphine (50 mg/kg) 
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Fig.3. Effects of phenytoin sodium upon the running responses of 
individual mice to an enkephalin analog. Mean + SD. Drugs ad- 
ministered 10 min and immediately prior to recording 
Testing was carried out in an illuminated environment with a 
continual masking noise of 25 dB. The activity monitors were set at 
the intermediate setting of the apparatus with a sensitivity of 30. The 
apparatus was recalibrated once during the experiment as noted 
below. Each testing cage (51 x 41 x 22 cm polypropylene cages, 
Scientific Products series 70) was placed upon the monitor with a 
fresh bedding of pine chips, Since composition of the bedding may 
affect drug metabolism (Vesell etal., 1973) we note that similar results 
regarding activity may be obtained on many different forms of 
bedding, or without any bedding whatsoever, Moreover, all such 
metabolic effects are at least to our knowledge chronic in nature as 
opposed to acute exposure. Additional details of apparatus and 
procedure have been published previously (Katz et al., 1978a, b). 
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Fig. 2. Carbamazepine facilitation of running induced in mice by 
morphine, Mean _ SD, Symbols: 9 Saline vehicle (S); 9 carbama- 
zepine (C); * morphine (M) (50 mg/kg); A morphine (50 mg/kg) + 
carbamazepine (10 rag); 9 morphine (50 mg/kg) + carbamazepine 
(20 mg/kg); [] morphine (50 mg/kg) + carbamazepine (50 mg/kg) 
Effects of Carbam(~zepine on Endorphin Mediated Running 
525 
I D-Ala 2 Analog Carbamo.zepine 450 
[ ~ 12.5 20 
- 
E ~ - -  20 







30 60 90 T / m i n .  
Fig. 4. Effects of carbamazepine upon the running responses of indi- 
vidual mice to an enkephalin analog. Mean +_ SD. Drugs adminis- 
tered 10 rain and immediately prior to recording 
It will be noted that all groups in Figs. 2 and 4 are higher than in 
Figs. 1 and 3. This includes both control and experimental animals. 
This was due to a recalibration of sensors between the two experi- 
ments, which yielded higher readings across conditions for a standard 
amount of movement. We emphasize these relative changes do not 
reflect altered running in the two figures, hut merely measurement 
differences over several months. 
Drugs and Injection Procedure. Morphine sulphate (Wyeth) was given 
at a dose of 50 mg/kg IP. Phenytoin sodium (Dilantin, Parke-Davis) 
was similarly administered in doses of 5, 10, and 20 mg/kg. 
Carbamazepine (Tegretol, Ciba-Geigy) was injected at 10, 20, and 
50 mg/kg. A 0.9 ~ saline vehicle was used for all injections including 
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controls, except for carbamazepine which was injected as suspension 
in i ~ Tween-80 solution in saline again with the appropriate vehicle 
serving as control. All injections were administered 1 ml, 0.1 kg and 
were based on the established pharmacology of each compound 
(Woodbury and Fingl, 1975). 
Behavioral Procedure. Morphine-injected mice were tested with cage 
mates in groups of four. Cage mates exceeding four were routinely 
discarded to standardize testing. This represented a similar pro- 
portion (20 ~) for all groups. Habituation began at 9 a.m., with initial 
injections i - 2  p.m. The initial injection of phenytoin, carbama- 
zepine, or vehicle was followed 5 rain later by an injection of 
morphine or vehicle. Experimental recording began immediately 
after the second injection. Ten minute recording intervals were used 
throughout the next 180 rain. A minimum of seven determinations 
(i.e., at least seven observations of the activity of grouped subjects) 
was made for each data point (range 7 - ! 1) for phenytoin, and three 
to eight determinations were made for carbamazepine. 
All data are presented as means and SE and were analyzed by 
analyses of variance. 
Results 
D u r i n g  ini t ia l  exposure  mice d i sp layed  ini t ia l ly  h igh 
act ivi ty  ( 3 0 0 0 - 4 0 0 0  coun t s /10  rain) which  decl ined  
m o n o t o n i c a l l y  over  a 2 -  3-h per iod.  The  final  2 h were 
charac te r ized  by  low (iess t h a n  50 coun t s /10  min)  or no  
activity.  A!I subjects  showed  zero act ivi ty  i mmed ia t e ly  
p reced ing  inject ion.  This  a l lowed a sensi t ive basel ine  
for e v a l u a t i n g  d rug  faci l i ta t ion.  M o r p h i n e  p r o d u c e d  
h igh  s table  rates of  act ivi ty  in  c o m p a r i s o n  to the vehicle 
(Figs. 1 a n d  2, respectively).  Inc reased  act ivi ty  was n o t  
seen after  e i ther  p h e n y t o i n  or c a r b a m a z e p i n e  given in  
the absence  o f  m o r p h i n e .  However ,  p h e n y t o i n  aug-  
m e n t e d  the behav io ra l  r esponse  to m o r p h i n e  in a dose- 
re la ted  m a n n e r  (Fig. 1) a n d  c a r b a m a z e p i n e  had  a 
s imi lar  effect (Fig. 2). 
To  insure  a p p r o x i m a t e  h o m o g e n e i t y  o f  var iance ,  
scores were t r a n s f o r m e d  pr ior  to analys is  ( square  r o o t  
of  coun t s  p ius  1). Ana lys i s  was t hen  by t r ea tmen t s -x -  
subjects  analys is  o f  va r i ance  wi th  cor rec t ion  for re- 
pea ted  measu res  ( B r u n i n g  a n d  Kin tz ,  I977).  Effects 
eva lua ted  were dose o f  drug,  t ime course  o f  d rug  ac t ion ,  
a n d  i n t e r ac t i on  o f  these factors.  
Ana lyses  of  va r i ance  ind ica ted  s ign i f ican t  effects o f  
g roups  [ F ( 5 , 4 8 ) =  16.7], t ime [ F ( 1 5 , 7 2 0 ) =  9.3], a n d  
i n t e r ac t i on  [F(75,720) = 4.3] (P  < 0.001 in at1 cases) in 
the in i t ia l  p h e n y t o i n  exper iment .  F o r  the c a r b a m a -  
zepine exper imen t ,  g roups  [ F ( 5 , 1 8 ) =  !3.3], t ime 
[F(15,185) = 9.1], a n d  i n t e r ac t i o n  [F(75, 185) = 3.7] 
were aga in  s ign i f i can t  (P  < 0.001 in all cases). 
Experiment H 
In  E x p e r i m e n t  I the anUepi lep t ic  drugs  p h e n y t o i n  a n d  
c a r b a m a z e p i n e  faci l i ta ted the n o r m a l  r u n n i n g  response  
of  g r o u p e d  mice to m o r p h i n e .  E x p e r i m e n t  H was 
i n t e n d e d  to ex tend  the genera l i ty  of  this f i nd ing  in 
three ways. A nove l  op ia te  (D-Ala 2 subs t i t u t ed  leu- 
e n k e p h a ! i n a m i d e )  was used to induce  r u n n i n g .  Mice 
were ind iv idua l ]y  tested, and  the pep t ide  was in jec ted  
central ly .  Cen t r a l  in jec t ions  were deemed  especia!ly 
i m p o r t a n t  since it migh t  be argued,  f rom pas t  experi-  
ments ,  tha t  the behav io ra l  fac i l i t a t ion  represen ted  an  
effect u p o n  d rug  d i spos i t ion  ra the r  t h a n  on  the cent ra l  
ac t iv i ty  o f  opiates.  Di rec t  in jec t ion  in to  the b r a in  
m i n i m i z e d  the poss ib i l i ty  of  m a j o r  changes  in the 
former .  
Materials and Methods 
Surgical and Behavioral Procedure. Except as indicated below ap- 
paratus and procedures were identical to Experiment I. Mice were 
anesthetized with 80 mg/kg IP sodium pentobarbital (Nembutal), 
and stereotaxically implanted with a permanently indwelling 23 
gauge stainless steal cannula constructed from a hypodermic syringe. 
The cannula was aimed at the lateral ventricle using coordinates from 
Slotnick and Leonard (1975) and secured to the skull with stainless 
steel screws and acrylic dental cement. A removable wire obturator 
was used to maintain patency and normal cleanliness. Seven days 
were allowed for recovery from surgery. Histology at the close of 
testing infolved injection of 5 ~I of commercially available black ink; 
anhnals were killed 5 -  I0 rain later and the ventricular surface was 
examined. Only subjects showing diffusion of ink throughout the 
ventricles were included in the analysis. 
The behavioral procedure consisted of five initial habituation 
sessions of 4 h each. Subjects were individually exposed to the testing 
chambers without any injections. After habituation, subjects were 
exposed to the chambers between 4 5 p. m. and allowed to habituate 
to a point of no movement as registered upon the sensors. This 
generally required an additional 3 h. Each mouse was then removed 
and briefly injected with either vehicle or drug in four combinations 
(vehicle alone, phenytoin or carbamazepine alone, enkephalin analog 
alone, combined treatment with phenytoin or carbamazepine, and 
enkephalin analog). A minimum of 48 h separated the test periods. 
Order of injection was systematically rotated across subjects with all 
subjects receiving aI1 treatments. Activity was recorded for ten blocks 
of 10 min each. 
Drugs. Based upon previous experiments in ore laboratory (Katz et 
al., I978a, b) and Experiment [, the following drug doses were 
employed: 12.5 p.g of D-Ala 2 leu-enkephalinamide (Peninsula 8619; 
Tyr D-Ala Gly Phe Leu-NH); 20 mg/kg of both phenytoin (Warner 
Lambert/Parke Davis) and carbamazepine (Ciba-Geigy). For the 
anaiog and its vehicle 5 ~_tl of Ringer-Locke solution was microin- 
jected within 30 s through the permanently indwelling cannula by use 
of a manually operated Hamilton microsyringe. The recording ses- 
sion began immediately after injection. The test drugs were adminis- 
tered IP (1 mg/0.I kg) using a 0.9 ~ sodium chloride vehicle solution 
for phenytoin and a I ~, Tween-80 in saline suspension vehicle for 
carbamazepine. The latter drugs were administered g0 rain prior to 
the start of the session. 
tt should be noted that the dose of enkephalin analog was a 
relatively modest one for the production of running (Katz et al., 
1.978a) and the doses of phenytoin and carbamazepine represented 
relatively high and moderate doses respectively (see Experiment I). 
GeneraJ Results 
Detai ls  o f  the stat is t ical  analys is  are p resen ted  in 
E x p e r i m e n t  I. However ,  the p resen t  analys is  ut i l ized a 
comple te  fac tor ia l  design as descr ibed  by  B r u n i n g  a n d  
K i n t z  (1977). A g a i n  a t r a n s f o r m a t i o n  based  u p o n  the 
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square root + 1 was used to initially equate variance. 
The results of Experiment II are consistent with the first 
experiment in that a low dose of opiate produced a 
modest running response that was increased up to 
threefold by the other drugs. Figure 3 presents the 
results for phenytoin effects upon D-AIa 2 leu- 
enkephalinamide which are significant for treatments, 
time, and interaction (respectively, F = 8.6, d f =  3,18 
P < 0 . 0 1 ;  F=14 .1 ,  df=9,54,  P<0 .001 ;  F = 4 . 3 ,  
d[= 27,162, P < 0.001). Figure4 presents similar 
results for carbamazepine, again main effects and inter- 
action are significant (respectively, for groups, time, 
and interaction, F =  5.1, 8.7, 3.7; df= 3,21, 9,56, 
189, P < 0.05, 0.001, 0.001). 
Discussion 
Based upon the present findings of potentiation of an 
opiate-induced behavioral syndrome, it appears pos- 
sible that some aspects of motor behavior which are 
affected by phenytoin or carbamazepine normally 
inhibit routine activity after opioids. The pharma- 
cological and biochemical differences of two anticom 
vulsants are considerable (Woodbury and Fingl, 1975). 
This further supports the possibility that their shared 
antiepileptic activity contributes to the findings, since 
structurally dissimilar compounds have the same effect. 
While one mechanism for the action of these drugs rests 
with their effects upon electrocortical seizures, it would 
be premature to state unequivocably that this is the sole 
mediator of the observed effect. Alterations in sensory 
activity and other pharmacological actions, cannot 
be disregarded as potential contributors. Clearly an 
examination of EEG patterns would be helpful in 
further elucidating these effects. 
In Experiment iI the same anticonvulsant drugs 
potentiated the murine activity response to a potent 
and long-lasting analog of an endogenous CNS pep- 
tide. This is clearly consistent with Experiment I and, 
given the procedural modifications with respect to the 
latter, argues that the observed effect is not dependent 
upon drug disposition. In addition to demonstrating 
the predicted drug interaction, these results confirm 
earlier reports from our laboratory demonstrating a 
running response to enkephalin analogs (Katz et al., 
1978a). 
Earlier findings suggested that at least some forms 
of morphine-induced activation were seizure- 
dependent, for example, phenytoin pretreatment was 
reported to eliminate opiate-induced feline mania 
(Fertziger et al., 1974). Phenytoin also has been shown 
to reduce morphine-induced catalepsy in rats (Cookson 
and Mann, 1978). It may be concluded that the 
responses induced by morphine must be evaluated 
carefully within and across species and testing 
situations. 
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